ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Race and Socioeconomic Disparities in Organ Type, Recovery and Readmission in Kidney Transplant Recipients

    A. Crane, T. Coy, N. Yerram, M. Eltemamy, E. Poggio, R. Fatica, A. Wee, C. Modlin, V. Krishnamurthi.

  • Race, Income, and Insurance Status Predict Migration for Liver Transplantation in the United States

    A. Kwong, A. Mannalithara, W. Kim.

  • Race/Ethnicity and Hypertension Self-Care Behaviors among US Living Kidney Donors

    M. Johnson, T. Purnell, X. Luo, L. Cooper, M. Waldram, D. Crews, M. Henderson, A. Massie, D. Segev.

  • Racial and Ethnic Disparities in Preemptive Transplantation before and after the Introduction of Kidney Allocation System, in Pediatric and Young Adult End Stage Renal Disease Patients

    R. George,1 M. Basu,2 R. Garro,1 J. Hogan,1 R. Patzer.2

  • Racial and Socioeconomic Influences on Kidney Transplantation. A 10 Year Retrospective Study

    A. Arvelakis, S. Lerner, V. Wadhera, V. Delaney, S. Ames, V. Shegal, R. Kent, G. DeBoccardo, N. Singh, S. Florman, R. Shapiro.

  • Racial Differences in Patient-Perceived Barriers to Starting the Kidney Transplant Evaluation

    R. Hamoda, L. McPherson, K. Lipford, J. Gander, S. Pastan, R. Patzer.

  • Racial Differences in Rates of Malignant and Infectious Cutaneous Genital Disease after Solid Organ Transplantation

    M. Larijani,1 K. Nadhan,1 J. Abbott,1 A. Doyle,2 C. Chung.1

  • Racial Disparities in Post-Liver Transplant Survival before and after Share 35 Implementation

    K. Ross,1 R. Lynch,2 R. Patzer.1,2

  • Racial/Ethnic Disparities in Living Donor Kidney Transplantation before and after the New National Kidney Allocation System

    X. Zhang,1 T. Melanson,2 L. Plantinga,3,6 M. Basu,1 S. Pastan,1,7 S. Mohan,4,5 M. Garber,6 R. Patzer.1,6,7

  • Racing to Activation: Using LEAN Principles to Effectively Manage Your Waitlist with Predicted Improved Outcomes

    L. Curry, V. Rao, D. Cassidy, V. Rohan, D. Dubay, N. Pilch, S. Gray.

  • Radiation Exposure to the Transplant Surgeon: A Case Study of Recent Yttrium-90 Treatment in an Explanted Liver

    M. Decoteau,1 P. Lewis,1 S. Steuterman,2 R. Schaffer,1 J. Fisher,1 J. Case,1 C. Marsh.1

  • Radioisotopic Evaluation of Glomerular Filtration Rate (GFR) before and 1 Year after Kindey Donation for Transplantation: The Concept of Estimated Renal Functional Reserve (eRFR)

    V. Cantaluppi,1 G. Guglielmetti,1 M. Mora,1 A. Airoldi,1 F. Orsini,2 M. Quaglia,1 G. Sacchetti,2 C. Ronco.3

  • Rapamycin Impairs Human Endothelial Cell Alloimmunogenicity Independent of PD-1/PD-1 Ligand Inhibitory Signaling

    Q. Gao, V. Bendersky, A. Kirk, H. Xu.

  • Rapamycin Therapy Impairs Treg Expression of CXCR3 and Limits Treg-Dependent Survival of Vascularized Composite Allotransplants

    H. Xu,1 Z. Chen,2 W. Hancock,3,4 S. Levin,5 Y. Zhang.1

  • Rates of Posttransplant Cutaneous Disease Differ between Black and White Solid Organ Transplant Recipients

    R. Allawh,1 K. Nadhan,1 A. Doyle,2 M. Harhay,3 C. Chung.1

  • Re-Endothelialization of Liver Xenografts Utilizing Human Endothelial Cells

    W. Hassanein,1 P. Patel,1 A. Werdsheim,1 J. Brilliant,1 E. Buckingham,1 N. Shockcor,1 C. Drachenberg,2 R. Barth,1 J. LaMattina.1

  • Re-Hospitalization after Pediatric Kidney Transplantation in Steroid Avoidance Protocols

    P. Verghese, S. Chinnakotla, D. Berglund, A. Matas, B. Chavers.

  • Re-Transplantation for Hepatic Artery Thrombosis: A National Perspective

    C. Garcia, X. Mei, F. Marti, M. Shah, J. Berger, M. Daily, M. Gupta, R. Gedaly.

  • Real-Time Expert Evaluation of Liver Biopsy for Transplant: The Significance of Smartphone and Microscope Adapter in Telepathology

    N. Bath,1 X. Wang,2 J. Bledsoe,2 M. Thijssen,1 A. Ahearn,1 B. Movahedi,1 A. Bozorgzadeh,1 P. Martins.1

  • Reassessment of Virtual Crossmatch: The Clinical Meaning of Cell-Based Actual Crossmatch for Kidney Transplantation

    B. Peng,1,2 M. Yu,1,2 Q. Zhuang,1,2 H. Liu,1,2 L. Zhu,1,2 Y. Liu,1,2 K. Cheng,1,2 Y. Ming.1,2

  • Receiving Hypertensive Donor Has an Inferior Prognosis in Simultaneous Liver Kidney Transplantation Recipient

    Z. Guo, Z. Zhu, S. Huang, Y. Tang, Z. Zhang, X. He, G. Chen.

  • Recent Exposure to Four-Factor Prothrombin Complex Concentrate (4F-PCC) is Associated with Intracardiac Thrombus during Liver Transplantation

    M. Misel,1,2 G. Schnickel,1 J. Berumen,1 R. Sanchez,3 K. Mekeel.1

  • Recipient ABO Blood-Type is Associated with Their Survival after Adult-to-Adult Living-Donor Liver Transplantation: Blood-Type O is Disadvantage?

    T. Goto,1 K. Hata,1 M. Nagao,2 J. Kusakabe,1 Y. Okamura,1 T. Tajima,1 I. Tamaki,1 Y. Nigmet,1 T. Tajima,1 J. Yoshikawa,1 H. Tanaka,1 S. Ichiyama,2 S. Uemoto.1

  • Recipient Conditioning Results in IL-33 Support of Potent Th1 Alloimmune Responses after CD4+ T Cells Upregulate ST2 during Lymphopenia Induced Proliferation

    G. Dwyer,1 L. Mathews,1 A. Lucas,1 B. Blazar,2 H. Turnquist.1

  • Recipient HO-1 Deficiency Decreases Post-Transplant Graft HO-1 Expression and Exacerbates Liver Transplant Damage

    S. Kageyama,1 K. Nakamura,1 T. Ito,1 A. Aziz,1 B. Ke,1 R. Sossa,2 E. Reed,2 F. Kaldas,1 R. Busuttil,1 J. Kupiec-Weglinski.1

  • Recipient IFNAR1 Signaling Supports Costimulation Independent Rejection by Promoting T Cell Activation

    D. Mathews, A. Ghosh, Y. Dong, K. Polireddy, A. Stephenson, C. Breeden, Y. Liu, A. Adams.

  • Recipient Outcomes in Age Mismatched Living Kidney Transplants from Donors > 60 Years: A UNOS Database Analysis

    O. Adebiyi, A. Riaz, M. Yaqub, D. Mishler, T. Taber, A. Sharfuddin.

  • Recombinant Relaxin Protects Liver Transplants from Ischemia-Reperfusion Damage via Hepatocyte Glucocorticoid Receptor: From Bench-to-Bedside

    S. Kageyama,1 K. Nakamura,1 T. Ito,1 A. Aziz,1 B. Ke,1 R. Sossa,2 E. Reed,2 F. Kaldas,1 R. Busuttil,1 J. Kupiec-Weglinski.1

  • Recombinant Thrombomodulin alpha Attenuates Kidney Graft Damage after Long Cold Ischemia Time in a Rat Kidney Transplant Model

    S. Tamaki,1 K. Shinoda,1 M. Shimoda,2 S. Morita,1 H. Asanuma,1 M. Oya.1

  • Recovery of Wild-Type Genotype after Documented Ganciclovir-Resistance in Transplant Recipients with Recurrent CMV Viremia

    J. Fose, M. Jorgenson, Z. Degrave, R. Redfield, J. Smith, D. Mandelbrot.

  • Recurrence of Focal Segmental Glomerulosclerosis (FSGS) and Response to Prolonged Plasmapheresis Therapy: A Single Center Pediatric Experience

    A. Bobrowski, D. Matossian.

  • Recurrence of Immunoglobulin A Nephropathy in Related Donor Kidney Transplant Recipients

    M. Okumi,1 D. Okada,1 K. Unagami,2 Y. Kakuta,1 H. Shirakawa,3 T. Shimizu,4 K. Omoto,4 H. Ishida,1 K. Tanabe.1

  • Recurrent FSGS Post-Transplantation: Prevalence and Risk Factors

    R. Aguiar,1 A. Gasparini,2 P. Chowdhury,1 D. Game,1 D. Moutzouris.1

  • Redo Kidney Transplant in FSGS

    J. Verbesey, A. Javaid, S. Yi, G. Vranic, A. Gilbert, P. Abrams, S. Ghasemian, J. Moore, B. Thomas, M. Cooper, B. Javaid.

  • Reduced Ratio of FoxP3/ RORγt Gene Expression, in Peripheral Blood, is Associated with Acute Allograft Rejection in Recipients with Kidney Transplantation

    R. Dhital,1,2 R. Minz,3 M. Minz,1,4 A. Sharma,1 R. Nada,5 S. Singh,1 D. Kenwar,1 S. Anand.3

  • Reducing Discards for Deceased Kidney Donors over Age 50 by Restricting Biopsy Criteria

    C. Hostetler, J. Rogge, B. Nicely, S. Rudich.

  • Reducing Hospital Readmissions: Referral of High Risk Liver Transplant Patients to a Transitional Care Coordination(TCC) Program

    A. Masoumi,1 R. Barth,2 T. Stern,1 D. Bruno,2 J. LaMattina,2 S. Hanish.2

  • Reducing No-Show Rate and Filling Cancelled Appointments: Multi-Faceted Interventions Markedly Reduced Time to Kidney Transplant Evaluation

    E. Gibney, K. Payne, C. Fowler.

  • Reduction in Circulating CD19+CD24+CD27+ Regulatory B Cell Frequency Predicts Acute Rejection in Liver Transplant Patients

    H. Zhou, Z. Rao, Y. Lu, J. Rao, J. Gu, L. Lu, Y. Xia.

  • Regional Variation in the Outcomes of MELD-Na Based Liver Allocation

    L. Chau,1 D. Moonka,2 K. Collins,1 M. Rizzari,1 A. Yoshida,1 M. Abouljoud,1 S. Nagai.1

  • Regression of Left Atrial Diameter after Kidney Transplantation is Associated with Prolonged Survival: An Observational Study

    A. Kainz,1 F. Regele,1 M. Kammer,2 A. Beer,3 R. Steringer-Mascherbauer,4 T. Binder,5 R. Oberbauer.1

  • Regulation of Indoleamine 2,3-Dioxygenase in Porcine Kidney Transplants

    Y. Wang,1 X. Fang,1 D. Kleven,1 C. Ho,2 S. Nahman,1,3 T. Merchen.1

  • Regulation of NK Cell Cytotoxicity by TEC Expression of Clr Proteins in Kidney Ischemia Reperfusion Injury (IRI)

    B. Fuhrmann,1,5 D. Lian,5 Z. Yin,5 S. Ma,4,5 J. Arp,5 Z. Zhang,2,3,4,5 A. Jevnikar.1,3,4,5

  • Regulatory Dendritic Cell (DCreg) Cell Infusion in Living Donor Liver Transplantation

    A. Thomson, A. Humar, F. Lakkis, S. Styn, A. Zahorchak, C. Macedo, D. Metes.

  • Rejection and Graft Loss in Patients with BK Viremia after Simultaneous Pancreas and Kidney Transplant

    D. Keys, S. Riad, V. Vakil, S. Jackson, D. Berglund, A. Matas, R. Kandaswamy.

  • Relation between Seroprevalence of Cytomegalovirus and Graft Survival in Japanese Kidney Transplant Recipients: The Japan Academic Consortium of Kidney Transplantation Study

    K. Miyake,1,2 M. Okumi,1 K. Unagami,3 Y. Kakuta,1 H. Shirakawa,4 K. Omoto,5 H. Ishida,1 K. Tanabe.1

  • Relationship between Living Kidney Donor Follow-Up GFR and Recipient Graft Loss

    C. Holscher,1 T. Ishaque,1 C. Haugen,1 S. DiBrito,1 K. Jackson,1 A. Muzaale,1 A. Massie,1,2 M. Henderson,1 J. Garonzik Wang,1 D. Segev.1,2,3

  • Relationship between Mixed Chimerism and Acceptance of HLA-Matched and Mismatched Kidney Transplants after Withdrawal of Immunosuppressive Drugs

    J. Scandling, S. Busque, R. Lowsky, J. Shizuru, K. Jensen, A. Shori, E. Engleman, E. Meyer, R. Hoppe, S. Strober.

  • Reliability of Bronchiolitis Obliterans Syndrome Reporting to the OPTN

    R. Carrico,1 R. Lehman,1 K. Uccellini,1 K. Chan,2 T. Whelan.3

  • Reliability of Deceased Donor Procurement Biopsy Images at the Time of Kidney Allocation

    S. Mansour,1 E. Hall,2 P. Reese,3 Y. Jia,1 H. Thiessen-Philbrook,1 G. Moeckel,1 F. Weng,4 P. Revelo,2 M. Khalighi,2 A. Trivedi,5 M. Doshi,6 B. Schroppel,7 C. Parikh.1

  • Renal Allograft Cortical Perfusion Quantification by 3D-Arterial Spin Labeling Could Be Used to Identify Subclinical Antibody-Mediated Rejection

    W. Wang,1 J. Wen,2 F. Xu,2 Y. Yu,3 L. Zhang,3 Z. Liu.2

  • Renal Allograft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation

    L. Gallon,1 J. Mathew,1 S. Bontha,2 C. Dumur,2 P. Dalal,1 L. Nadimpalli,1 D. Maluf,2 A. Shetty,1 S. Ildstad,3 J. Leventhal,1 V. Mas.2

  • Renal Allograft Transplantation among Middle Eastern Population with Alemtuzumab Induction

    G. Mitro, O. Ekwenna, M. Rees, J. Ortiz.

  • Renal and Bone Safety in Post Liver Transplant Patients with Chronic Kidney Disease Receiving Tenofovir Alafenamide for HBV Prophylaxis

    E. Gane,1 B. George,1 S. Munn,1 H. Wang,2 V. Suri,2 A. Gaggar.2

  • Renal Function, Blood Pressure, and Histologic Changes in Living Kidney Transplant Recipients from Hypertensive Donors

    T. Dienemann, J. Schellenberg, K. Amann, K. Heller, A. Weidemann.

  • Renal Transplant Outcomes in Recipients Weighing 8-10 Kilograms

    P. Singer, Y. Tseng, C. Sethna, L. Castellanos-Reyes, E. Molmenti, A. Fahmy, E. Grodstein, L. Teperman.

  • Renal-Sparing Protocol May Be Harmful If Performed Early Post-Heart Transplant

    J. Patel, M. Johl, E. Kransdorf, M. Kittleson, S. Dimbil, R. Levine, D. Chang, L. Czer, J. Kobashigawa.

  • Repeat Kidney Transplant Patients with Active Rejection Have Elevated Donor-Derived Cell-Free DNA

    S. Mehta,1 J. Chang,2 T. Hailey,1 D. Hiller,3 M. Grskovic,3 J. Yee,3 R. Mannon.1

  • Reported Effects of the SRTR 5-Tier Rating System on US Transplant Centers

    S. Rasmussen,1 A. Thomas,1 J. Garonzik-Wang,1 M. Henderson,1 S. Stith,2 D. Segev,1 L. Hersch Nicholas.1

  • Resident Perceptions and Evaluations of a Fellow-Led Transplant Service versus Resident-Led Surgical Services

    A. Williams, M. Barrett, N. Matusko, S. Dennahy, R. Sung, G. Sandhu, K. Woodside.

  • Respiratory Viral Infections Induces Exosomes and Antibodies to Lung Self-Antigens, Kα1Tubulin and Collagen V, Following Human Lung Transplantation

    M. Gunasekaran,1 S. Bansal,1 M. Sharma,1 R. Walia,1 R. Hachem,2 A. Limaye,3 R. Bremner,1 M. Smith,1 T. Mohanakumar.1

  • Results of LITMUS (NCT 02541916): The Liver Immune Tolerance Bio Marker Utilization Study

    A. Chruscinski,1 V. Rojas-Luengas,1 A. Issacher,1 J. Luo,4 H. Yowanto,4 N. Selzner,1 L. Lilly,1 R. Smith,1 E. Renner,1 J. Zhang,1 D. Grant,1 O. Adeyi,1 H. Atkins,2 P. Juni,3 G. Levy.1

  • Results of UNOS Survey on Diagnosis, Treatment and Follow-Up Evaluation of Clinical and Sub-Clinical TCMR and ABMR in Kidney Transplant Recipients

    P. Sood,1 W. Cherikh,2 A. Toll,2 R. Mehta,1 C. Puttarajappa,1 S. Hariharan.1

  • Resuscitation and Viability Testing of Initially Declined Livers Using Sequential Hypo- and Normothermic Machine Perfusion with an Acellular Fluid

    Y. de Vries,1,2 A. Matton,1,2 S. Karangwa,1,2 M. Nijsten,3 R. de Kleine,2 A. van den Berg,4 V. de Meijer,2 P. Meyer,5 M. de Boer,2 R. Porte.2

  • Retransplantation after Living Donor Liver Transplantation: Analysis of Data from the A2ALL Study

    H. Braun, J. Grab, J. Dodge, S. Syed, G. Roll, C. Freise, J. Roberts, N. Ascher.

  • Retrospective Study of Cryptococcosis in Kidney Transplant Recipients from a Single Center

    R. Wang, M. Cen, J. Lin, H. Huang, W. Peng, J. Wu.

  • Rhesus Monkey Have natural Antibody toward Swine That is Not Influenced by Allosensitization nor by Carfilzomib/tocilizumab

    J. Yoon, B. Ezekian, M. Manook, J. Kwun, S. Knechtle.

  • Rhesus-Specific Anti-Thymocyte Globulin as an Adjuvant to Costimulatory-Blockade-Based Immunotherapy

    M. Mulvihill,1 B. Ezekian,1 Q. Gao,1 K. Samy,1 R. Davis,1 F. Leopardi,1 A. Belli,2 W. Flores,2 A. Buzby,2 K. Reimann,2 B. Collins,1 A. Kirk.1

  • Rictor mTORC2 Signaling Protects Ischemic Liver Injury by Targeting Both Liver Parenchymal and Non-Parenchymal Cells

    H. Zhou,1 Z. Rao,1 R. Liu,1 S. Zhou,1 J. Rao,1 J. Gu,1 H. Lu,1 Y. Xia,1 X. Wang,1 Y. Zhai,2 L. Lu.1

  • Risk Factors and Outcomes with Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections among Solid Organ Transplant Recipients

    J. Anesi,1 E. Blumberg,1 E. Lautenbach,1 J. Omorogbe,1 P. Tolomeo,1 P. Tamma,2 K. Thom,3 K. Alby,1 W. Bilker,1 A. Werzen,3 K. Nemati,2 J. Han.1

  • Risk Factors and Outcomes with Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Bloodstream Infections among Solid Organ Transplant Recipients

    J. Anesi,1 E. Blumberg,1 E. Lautenbach,1 P. Tamma,2 K. Thom,3 K. Alby,1 W. Bilker,1 J. Omorogbe,1 P. Tolomeo,1 A. Werzen,3 K. Nemati,2 J. Han.1

  • Risk Factors and Sequelae of Post-KT Delirium

    M. McAdams DeMarco, A. Mountford, F. Warsame, R. Berkowitz, H. Ying, C. Haugen, D. Brennan, D. Segev.

  • Risk Factors for Chronic Opioid Use after Kidney Transplantation

    J. Fleming, D. Taber, R. Gilbert, L. Wilson, Z. Elmaasarani, B. O'Brien, N. Patel, N. Pilch, S. Ball, P. Mauldin, P. Baliga.

  • Risk Factors for Chronic Opioid Use after Liver Transplantation

    J. Fleming, D. Taber, B. O'Brien, N. Patel, N. Pilch, R. Gilbert, L. Wilson, Z. Elmaasarani, S. Ball, P. Mauldin, P. Baliga.

  • Risk Factors for Failure to Complete Post-Donation Follow-Up among Obese Living Kidney Donors

    R. Reed,1 P. MacLennan,1 B. Shelton,1 M. Mustian,1 D. McWilliams,1 D. Sawinski,2 J. Locke.1

  • Risk Factors for Graft Failure in Kidney Transplant Recipients with Polycystic Kidney Disease

    G. Bhutani, B. Astor, A. Djamali.

  • Risk Factors for Invasive Fungal Infections among Lung Transplant Recipients

    K. Whitaker, J. Anesi, E. Blumberg, L. Gardo, J. Lee, M. Crespo, C. Bermudez, L. Glaser, M. Wilck.

  • Risk Factors for Postoperative Bleeding after Lung Transplantation

    D. Adelmann,1,2 S. Koch,1 J. Menger,1 P. Jaksch,3 M. Kurz,1 M. Mouhieddine,1 W. Klepetko,3 B. Steinlechner.1

  • Risk Factors of De Novo Malignancies after Liver Transplantation

    M. Altieri,1 O. Seree,2 J. Dumortier,3 GREF2 Groupe de Recherche Français en Greffe de Foie.

  • Risk of Bacteremia According to Transplant Induction Immunosuppression Regimen

    E. Misch, S. Kelley, G. Leverson, B. Astor, D. Kaufman.

  • Risk of ESRD in Prior Living Kidney Donors

    J. Wainright, A. Robinson, A. Wilk, D. Klassen, W. Cherikh, D. Stewart.

  • Risk of Infection in Treatment of Acute Cellular Rejection in Heart Transplant Recipients

    T. Fallah, A. Logan, A. Rumore, C. Doligalski.

  • Rituximab Induction to Prevent the Recurrence of PSC after Liver Transplantation-The Lessons Learned from ABO-Incompatible Living Donor Liver Transplantation-

    Y. Yamada,1 K. Hoshino,1 M. Shinoda,1 H. Obara,1 S. Uemoto,3 T. Kaido,3 H. Okajima,3 T. Yagi,4 T. Yoshizumi,5 Y. Inomata,6 T. Hibi,6 K. Kubota,7 T. Suzuki,8 Y. Kitagawa,1 H. Egawa,2 T. Kuroda.1

  • Rituximab Interference in B-Cell Crossmatch: A Problem Solved

    P. Malvezzi,1 O. Senoussi,2 T. Jouve,1 C. De Palma,2 L. Rostaing,1 B. Bardy,2 D. Masson.2

  • RNA Expression Profiling of Renal Allografts in a Non-Human Primate Identifies Inflammation as a Risk Factor in Chronic Antibody Mediated Rejection

    R. Smith,1 B. Adam,2 A. Rosales,1 M. Matsunami,3 T. Oura,3 B. Cosimi,3 T. Kawai,3 M. Mengel,2 R. Colviin.1

  • RNA Expression Profiling of Renal Allografts in the Cynomolgus Monkey Identifies Tolerance

    R. Smith,1 M. Matsunami,3 B. Adam,2 A. Rosales,1 T. Oura,3 A. Cosimi,3 T. Kawai,3 M. Mengel,2 R. Colvin.1

  • RNA-Seq Based Analysis of Renal Allograft Biopsies Reveals Key Mediators of Interstitial Fibrosis/Tubular Atrophy

    C. McEvoy,1,2,4 E. Brennan,1,2 A. Dorman,2,3 D. Sadlier,1,2 A. Konvalinka,4 P. Conlon,2,3 C. Godson.1,2

  • Robotic Assisted Live Donor Kidney Transplantation – Technique and Outcomes

    H. Pahari,1 B. Waldman,2 J. Stracke,1 L. Malinzak,1 J. Denny,1 D. Kim,1 W. Jeong,3 M. Menon,3 A. Yoshida.1

  • Robotic Kidney Transplantation in Obese Recipients: The New Standard?

    I. Tzvetanov, C. Di Bella, K. Tulla, M. Spaggiari, F. Gheza, P. Di Cocco, J. Oberholzer, E. Benedetti.

  • Robotic Pancreas Transplantation in Obese Recipients: Preliminary Results

    M. Spaggiari,1 C. Di Bella,1 P. Di Cocco,1 F. Gheza,1 E. Benedetti,1 I. Tzvetanov,1 J. Oberholzer.2

  • Robust Hematopoietic Mixed Chimerism and Donor-Specific Skin Allograft Tolerance after Non-Genotoxic Anti-CD117 Immunotoxin Conditioning and Donor Bone Marrow Allotransplantation

    Z. Li,1 A. Czechowicz,2,3,4,5,6,7 A. Scheck,2,3,4,5,6 D. Rossi,3,4,5,6 P. Murphy.1

  • Role of B Cell Intrinsic NLRP3 in the Development of Chronic Rejection

    J. Nie,1 B. Ramaswami,2 X. Guo,3 R. Hoffman,2 G. Chalasani.3

  • Role of BK Virus-Specific T Cell Immune Monitoring for BK Virus-Associated Nephropathy in Kidney Transplant Recipients

    J. Bruminhent,1 S. Srisala,2 C. Klinmalai,3 S. Pinsai,1 S. Watcharananan,1 S. Kantachuvessiri,5 S. Hongeng,4 N. Apiwattanakul.3

  • Role of C1q-Binding Donor-Specific Anti-HLA Antibodies in Premature and Accelerated Kidney Allograft Interstitial Fibrosis

    K. Louis, D. Viglietti, O. Aubert, A. Loupy, C. Lefaucheur.

  • Role of Calcium/Calmodulin Kinase IV on Podocyte Function in Transplant Glomerulopathy

    R. Bhargava, K. Maeda, A. Ferreti, M. Pavlakis, G. Tsokos.

  • Role of Obesity in Pediatric Liver Transplantation

    K. Covarrubias, M. Denhard, X. Luo, J. Garonzik-Wang, A. Cameron, D. Segev, D. Mogul.

Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences